Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms

Michael House, James G. Herman, Ming Zhou Guo, Craig M. Hooker, Richard D. Schulick, John L. Cameron, Ralph H. Hruban, Anirban Maitra, Charles J. Yeo, Herbert Chen

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background. The aberrant promoter methylation of the mismatch repair gene, hMLH1, is associated with microsatellite instability (MSI) in cancer cells and often is associated with a favorable prognosis. Methods. Pancreatic endocrine neoplasms (PENs) were obtained from 48 patients who underwent surgical resection. Methylation-specific polymerase chain reaction was used to detect methylation in the hMLH1 promoter. Tumor MSI at loci BAT26, BAT25, D2S123, D5S346, and D17S250 was determined with microsatellite polymerase chain reaction. Results. Hypermethylation of the hMLH1 promoter was present in 11 of 48 PENs (23%). Five of the 11 hMLH1-methylated PENs were found to be microsatellite unstable, and MSI was restricted to PENs with hMLH1 hypermethylation. Tumor recurrence at 2 years after surgical resection was significantly less common among the hMLH1-methylated PENs (11%), compared with the unmethylated PENs (35%; P = .035). Patients with hMLH1-methylated PENs experienced improved 5-year survival (100%) compared with patients with unmethylated tumors (56%; P = .010). Likewise, MSI-positive PENs were associated with improved survival compared with MSI-negative tumors (100% vs 59%; P = .017) at 5 years. Conclusion. As in hereditary nonpolyposis colorectal cancer in which MSI is associated with improved survival, methylation of hMLH1 leads to MSI in PENs and affords a favorable prognosis.

Original languageEnglish (US)
Pages (from-to)902-909
Number of pages8
JournalSurgery
Volume134
Issue number6
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Microsatellite Instability
Pancreatic Neoplasms
Methylation
Neoplasms
Microsatellite Repeats
Survival
Hereditary Nonpolyposis Colorectal Neoplasms
Polymerase Chain Reaction
DNA Mismatch Repair
Recurrence

ASJC Scopus subject areas

  • Surgery

Cite this

House, M., Herman, J. G., Guo, M. Z., Hooker, C. M., Schulick, R. D., Cameron, J. L., ... Chen, H. (2003). Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery, 134(6), 902-909. https://doi.org/10.1016/S0039-6060(03)00412-4

Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. / House, Michael; Herman, James G.; Guo, Ming Zhou; Hooker, Craig M.; Schulick, Richard D.; Cameron, John L.; Hruban, Ralph H.; Maitra, Anirban; Yeo, Charles J.; Chen, Herbert.

In: Surgery, Vol. 134, No. 6, 12.2003, p. 902-909.

Research output: Contribution to journalArticle

House, M, Herman, JG, Guo, MZ, Hooker, CM, Schulick, RD, Cameron, JL, Hruban, RH, Maitra, A, Yeo, CJ & Chen, H 2003, 'Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms', Surgery, vol. 134, no. 6, pp. 902-909. https://doi.org/10.1016/S0039-6060(03)00412-4
House, Michael ; Herman, James G. ; Guo, Ming Zhou ; Hooker, Craig M. ; Schulick, Richard D. ; Cameron, John L. ; Hruban, Ralph H. ; Maitra, Anirban ; Yeo, Charles J. ; Chen, Herbert. / Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. In: Surgery. 2003 ; Vol. 134, No. 6. pp. 902-909.
@article{eb89cd337ccf41ed82f04717f8197edb,
title = "Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms",
abstract = "Background. The aberrant promoter methylation of the mismatch repair gene, hMLH1, is associated with microsatellite instability (MSI) in cancer cells and often is associated with a favorable prognosis. Methods. Pancreatic endocrine neoplasms (PENs) were obtained from 48 patients who underwent surgical resection. Methylation-specific polymerase chain reaction was used to detect methylation in the hMLH1 promoter. Tumor MSI at loci BAT26, BAT25, D2S123, D5S346, and D17S250 was determined with microsatellite polymerase chain reaction. Results. Hypermethylation of the hMLH1 promoter was present in 11 of 48 PENs (23{\%}). Five of the 11 hMLH1-methylated PENs were found to be microsatellite unstable, and MSI was restricted to PENs with hMLH1 hypermethylation. Tumor recurrence at 2 years after surgical resection was significantly less common among the hMLH1-methylated PENs (11{\%}), compared with the unmethylated PENs (35{\%}; P = .035). Patients with hMLH1-methylated PENs experienced improved 5-year survival (100{\%}) compared with patients with unmethylated tumors (56{\%}; P = .010). Likewise, MSI-positive PENs were associated with improved survival compared with MSI-negative tumors (100{\%} vs 59{\%}; P = .017) at 5 years. Conclusion. As in hereditary nonpolyposis colorectal cancer in which MSI is associated with improved survival, methylation of hMLH1 leads to MSI in PENs and affords a favorable prognosis.",
author = "Michael House and Herman, {James G.} and Guo, {Ming Zhou} and Hooker, {Craig M.} and Schulick, {Richard D.} and Cameron, {John L.} and Hruban, {Ralph H.} and Anirban Maitra and Yeo, {Charles J.} and Herbert Chen",
year = "2003",
month = "12",
doi = "10.1016/S0039-6060(03)00412-4",
language = "English (US)",
volume = "134",
pages = "902--909",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms

AU - House, Michael

AU - Herman, James G.

AU - Guo, Ming Zhou

AU - Hooker, Craig M.

AU - Schulick, Richard D.

AU - Cameron, John L.

AU - Hruban, Ralph H.

AU - Maitra, Anirban

AU - Yeo, Charles J.

AU - Chen, Herbert

PY - 2003/12

Y1 - 2003/12

N2 - Background. The aberrant promoter methylation of the mismatch repair gene, hMLH1, is associated with microsatellite instability (MSI) in cancer cells and often is associated with a favorable prognosis. Methods. Pancreatic endocrine neoplasms (PENs) were obtained from 48 patients who underwent surgical resection. Methylation-specific polymerase chain reaction was used to detect methylation in the hMLH1 promoter. Tumor MSI at loci BAT26, BAT25, D2S123, D5S346, and D17S250 was determined with microsatellite polymerase chain reaction. Results. Hypermethylation of the hMLH1 promoter was present in 11 of 48 PENs (23%). Five of the 11 hMLH1-methylated PENs were found to be microsatellite unstable, and MSI was restricted to PENs with hMLH1 hypermethylation. Tumor recurrence at 2 years after surgical resection was significantly less common among the hMLH1-methylated PENs (11%), compared with the unmethylated PENs (35%; P = .035). Patients with hMLH1-methylated PENs experienced improved 5-year survival (100%) compared with patients with unmethylated tumors (56%; P = .010). Likewise, MSI-positive PENs were associated with improved survival compared with MSI-negative tumors (100% vs 59%; P = .017) at 5 years. Conclusion. As in hereditary nonpolyposis colorectal cancer in which MSI is associated with improved survival, methylation of hMLH1 leads to MSI in PENs and affords a favorable prognosis.

AB - Background. The aberrant promoter methylation of the mismatch repair gene, hMLH1, is associated with microsatellite instability (MSI) in cancer cells and often is associated with a favorable prognosis. Methods. Pancreatic endocrine neoplasms (PENs) were obtained from 48 patients who underwent surgical resection. Methylation-specific polymerase chain reaction was used to detect methylation in the hMLH1 promoter. Tumor MSI at loci BAT26, BAT25, D2S123, D5S346, and D17S250 was determined with microsatellite polymerase chain reaction. Results. Hypermethylation of the hMLH1 promoter was present in 11 of 48 PENs (23%). Five of the 11 hMLH1-methylated PENs were found to be microsatellite unstable, and MSI was restricted to PENs with hMLH1 hypermethylation. Tumor recurrence at 2 years after surgical resection was significantly less common among the hMLH1-methylated PENs (11%), compared with the unmethylated PENs (35%; P = .035). Patients with hMLH1-methylated PENs experienced improved 5-year survival (100%) compared with patients with unmethylated tumors (56%; P = .010). Likewise, MSI-positive PENs were associated with improved survival compared with MSI-negative tumors (100% vs 59%; P = .017) at 5 years. Conclusion. As in hereditary nonpolyposis colorectal cancer in which MSI is associated with improved survival, methylation of hMLH1 leads to MSI in PENs and affords a favorable prognosis.

UR - http://www.scopus.com/inward/record.url?scp=10744220882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744220882&partnerID=8YFLogxK

U2 - 10.1016/S0039-6060(03)00412-4

DO - 10.1016/S0039-6060(03)00412-4

M3 - Article

VL - 134

SP - 902

EP - 909

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 6

ER -